Exposure-response modeling of cabozantinib in patients with renal cell carcinoma : Implications for patient care - Castellano, Daniel (Hospital Universitario 12 de Octubre (Madrid)) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Benzaghou, Fawzi (Ipsen Pharma) ; Taguieva, Naila (Ipsen Pharma) ; Nguyen, Linh (Exelixis. Inc.) ; Clary, Douglas O. (Exelixis. Inc.) ; Jonasch, Eric W. (The University of Texas MD Anderson Cancer Center) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>